CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity

Experimental Dermatology

Volumn 14, Issue 4, 2005, Pages 250-258

  Nieuwenhuis, Edward E S ^a   Gillessen, Silke ^b   Scheper, Rik J ^c   Exley, Mark A ^d   Taniguchi, Masaru ^e   Balk, Steven P ^d   Strominger, Jack L ^c   Dranoff, Glenn ^b   Blumberg, Richard S ^a   Wilson, S Brian ^f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e CHIBA UNIVERSITY   (Japan)

^f Diabetes Research Laboratories   (United States)

Author keywords

Antagonists; CD1d; Cells; Contact hypersensitivity; iNKT; Lipids; Skin

Indexed keywords

CD1D ANTIGEN; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; GLYCOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; SKIN ALLERGY; STRAIN DIFFERENCE; SYSTEMIC THERAPY; T LYMPHOCYTE; WILD TYPE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; CELL LINE; DENDRITIC CELLS; DERMATITIS; DERMATITIS, CONTACT; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOLIPIDS; HYPERSENSITIVITY; KILLER CELLS, NATURAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; OXAZOLONE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; RECEPTORS, ANTIGEN, T-CELL;

EID: 20144388137     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2005.00289.x     Document Type: Article

References (72)

1. Eisen H N, Orris L, Belman S. Elicitation of delayed allergic skin reactions with haptens: the dependence of elicitation on hapten combination with protein. J Exp Med 1952: 95: 473-487.
2. Silberberg I, Baer R L, Rosenthal S A. The role of Langerhans cells in allergic contact hypersensitivity. A review of findings in man and guinea pigs. J Invest Dermatol 1976: 66: 210-217.
3. Dieli F, Taniguchi M, Asherson G L et al. Development of hapten-induced IL-4-producing CD4+ T lymphocytes requires early IL-4 production by alphabeta T lymphocytes carrying invariant V (alpha) 14 TCR alpha chains. Int Immunol 1998: 10: 413-420.
4. Ptak W, Askenase P W. Gamma delta T cells assist alpha beta T cells in adoptive transfer of contact sensitivity. J Immunol 1992: 149: 3503-3508.
5. Yokozeki H, Watanabe K, Igawa K, Miyazaki Y, Katayama I, Nishioka K. Gammadelta T cells assist alphabeta T cells in the adoptive transfer of contact hypersensitivity to para-phenylenediamine. Clin Exp Immunol 2001: 125: 351-359.
6. Ishii N, Takahashi K, Nakajima H, Tanaka S, Askenase P W. DNFB contact sensitivity (CS) in BALB/c and C3H/He mice: requirement for early-occurring, early-acting, antigen-specific, CS-initiating cells with an unusual phenotype (Thy-1+, CD5+, CD3-, CD4-, CD8-, sIg-, B220+, MHC class II-, CD23+, IL-2R-, IL-3R+, Mel-14-, Pgp-1+, J11d+, MAC-1+, LFA-1+, and Fc gamma RII+). J Invest Dermatol 1994: 102: 321-327.
7. Askenase P W. Yes T cells, but three different T cells (alphabeta, gammadelta and NKT cells), and also B-1 cells mediate contact sensitivity. Clin Exp Immunol 2001: 125: 345-350.
8. Tsuji R F, Szczepanik M, Kawikova I et al. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med 2002: 196: 1277-1290.
9. Campos R A, Szczepanik M, Itakura A et al. Cutaneous immunization rapidly activates liver invariant Valpha14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J Exp Med 2003: 198: 1785-1796.
10. Brigl M, Brenner M B. CD1: antigen presentation and T cell function. Annu Rev Immunol 2004: 22: 817-890.
11. Porcelli S A, Modlin R L. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999: 17: 297-329.
12. Godfrey D I, Hammond K J, Poulton L D, Smyth M J, Baxter A G. NKT cells: facts, functions and fallacies. Immunol Today 2000: 21: 573-583.
13. Baxter A G, Kinder S J, Hammond K J L, Scollay R, Godfrey DI. Association between abTCR+CD4-CD8- T-cell defiency and IDDM in NOD/Lt mice. Diabetes 1997: 46: 572-582.
14. Wilson S B, Kent S C, Patton K T et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998: 391: 177-181.
15. Naumov Y N, Bahjat K S, Gausling R et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci USA 2001: 98: 13838-13843.
16. Sharif S, Arreaza G A, Zucker P et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001: 7: 1057-1062.
17. Wang B, Geng Y B, Wang C R. Cd1-restricted nkt cells protect nonobese diabetic mice from developing diabetes. J Exp Med 2001: 194: 313-320.
18. Beaudoin L, Laloux V, Novak J, Lucas B, Lehuen A. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity 2002: 17: 725-736.
19. Akbari O, Stock P, DeKruyff R H, Umetsu D T. Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 2003: 15: 627-633.
20. Singh A K, Wilson M T, Hong S et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 2001: 194: 1801-1811.
21. Cui J, Shin T, Kawano T et al. Requirement for Va14 NKT cells in IL-12-mediated rejection of tumors. Science 1997: 278: 1623-1626.
22. Smyth M J, Thia K Y T, Street S E A et al. Differential tumor surveillance by natural killer (NK) and NKT Cells. J Exp Med 2000: 191: 661-668.
23. Kitamura H, Iwakabe K, Yahata T et al. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 1999: 189: 1121-1128.
24. Tomura M, Yu W-G, Ahn H-J et al. A Novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol 1999: 163: 93-101.
25. Toura I, Kawano T, Akutsu Y, Nakayama T, Ochiai T, Taniguchi M. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J Immunol 1999: 163: 2387-2391.
26. Zeng Z-H, Castano A R, Segelke B W, Stura E A, Peterson P A, Wilson I A. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 1997: 277: 339-345.
27. Naidenko O V, Maher J K, Ernst W A, Sakai T, Modllin R L, Kronenberg M. Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med 1999: 190: 1069-1079.
28. Joyce S, Woods A S, Yewdell J W et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 1998: 279: 1541-1544.
29. Brossay L, Kronenberg M. Highly conserved antigen-presenting function of CD1d molecules. Immunogenetics 1999: 50: 146-151.
30. Sonoda Kh, Exley M, Snapper S, Balk S P, Stein-Streilein J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site [see comments]. J Exp Med 1999: 190: 1215-1226.
31. Exley M A, Bigley N J, Cheng O et al. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol 2001: 69: 713-718.
32. Smiley S T, Kaplan M H, Grusby M J. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 1997: 275: 977-979.
33. Kawano T, Cui J, Koezuka Y et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycoceramides. Science 1997: 278: 1626-1629.
34. Gillessen S, Mach N, Small C, Mihm M, Dranoff G. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood 2001: 97: 922-928.
35. Nakajima A, Iijima H, Neurath M F et al. Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function. J Immunol 2002: 168: 1028-1035.
36. Gorski J, Yassai M, Zhu X et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 1994: 152: 5109-5119.
37. Naumov Y N, Naumova E N, Gorski J. CD4+ and CD8+ circulating alpha/beta T-cell repertoires are equally complex and are characterized by different levels of steady-state TCR expression. Hum Immunol 1996: 48: 52-62.
38. Apostolou I, Takahama Y, Belmant C et al. Murine natural killer T (NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci USA 1999: 96: 5141-5146.
39. Bacci S, Alard P, Dai R, Nakamura T, Streilein J W. High and low doses of haptens dictate whether dermal or epidermal antigen-presenting cells promote contact hypersensitivity. Eur J Immunol 1997: 27: 442-448.
40. Gocinski B L, Tigelaar R E. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990: 144: 4121-4128.
41. Gerlini G, Hefti H P, Kleinhans M, Nickoloff B J, Burg G, Nestle F O. Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. J Invest Dermatol 2001: 117: 576-582.
42. Naumov Y N, Hogan K T, Naumova E N, Pagel J T, Gorski J. A class I MHC-restricted recall response to a viral peptide is highly polyclonal despite stringent CDR3 selection: implications for establishing memory T cell repertoires in 'real-world' conditions. J Immunol 1998: 160: 2842-2852.
43. Bendelac A, Rivera M N, Park H-S, Roark JH. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 1997: 15: 535-562.
44. Hopkin J M. Mechanisms of enhanced prevalence of asthma and atopy in developed countries. Curr Opin Immunol 1997: 9: 788-792.
45. Akdis C A, Akdis M, Trautmann A, Blaser K. Immune regulation in atopic dermatitis. Curr Opin Immunol 2000: 12: 641-646.
46. Girolomoni G, Sebastiani S, Albanesi C, Cavani A. T-cell subpopulations in the development of atopic and contact allergy. Curr Opin Immunol 2001: 13: 733-737.
47. Stein-Streilein J. Invariant NKT cells as initiators, licensors, and facilitators of the adaptive immune response. J Exp Med 2003: 198: 1779-1783.
48. Smyth M J, Taniguchi M, Street S E. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol 2000: 165: 2665-2670.
49. Nieuwenhuis E E, Matsumoto T, Exley M et al. CD1d-dependent macrophage-mediated clearance of pseudomonas aeruginosa from lung. Nat Med 2002: 8: 588-593.
50. Matsuda J L, Naidenko O V, Gapin L et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers [see comments]. J Exp Med 2000: 192: 741-754.
51. Crowe N Y, Uldrich A P, Kyparissoudis K et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 2003: 171: 4020-4027.
52. Seino K, Harada M, Taniguchi M. NKT cells are relatively resistant to apoptosis. Trends Immunol 2004: 25: 219-221.
53. Nickoloff B J, Wrone-Smith T, Bonish B, Porcelli S A. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol 1999: 135: 546-552.
54. Mempel M, Flageul B, Suarez F et al. Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire. Am J Pathol 2000: 157: 509-523.
55. Mempel M, Ronet C, Suarez F et al. Natural killer T cells restricted by the monomorphic MHC Class Ib CD1d1 molecules behave like inflammatory cells. J Immunol 2002: 168: 365-371.
56. Bonish B, Jullien D, Dutronc Y et al. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells. J Immunol 2000: 165: 4076-4085.
57. Gilleron M, Ronet C, Mempel M, Monsarrat B, Gachelin G, Puzo G. Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guerin and ability to induce granuloma and recruit natural killer T cells. J Biol Chem 2001: 276: 34896-34904.
58. Okazaki F, Kanzaki H, Fujii K et al. Initial recruitment of interferon-gamma-producing CD8+ effector cells, followed by infiltration of CD4+ cells in 2,4,6-trinitro-1-chlorobenzene (TNCB)-induced murine contact hypersensitivity reactions. J Dermatol 2002: 29: 699-708.
59. Sebastiani S, Allavena P, Albanesi C et al. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 2001: 166: 996-1002.
60. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000: 114: 295-302.
61. Mendiratta S K, Martin W D, Hong S, Boesteanu A, Joyce S, Van Kaer L. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997: 6: 469-477.
62. Bendelac A, Hunziker R D, Lantz O. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J Exp Med 1996: 184: 1285-1293.
63. Akbari O, Stock P, Meyer E et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med 2003: 9: 582-588.
64. Heller F, Fuss I J, Nieuwenhuis E E, Blumberg R S, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002: 17: 629-638.
65. Yang O O, Racke F K, Nguyen P T et al. CD1d on myeloid dendritic cells stimulates cytokine secretion and cytolytic activity of Valpha24JalphaQ T Cells: a feedback mechanism for immune regulation. J Immunol 2000: 165: 3756-3762.
66. Wilson S B, Kent S C, Horton H F et al. Multiple differences in gene expression in regulatory Valpha24JalphaQ T cells from identical twins discordant for type I diabetes. Proc Natl Acad Sci USA 2000: 97: 7411-7416.
67. Exley M, Garcia J, Balk S P, Porcelli S. Requirements for CD1d recognition by human invariant Va24+ CD4-CD8- T Cells. J Exp Med 1997: 186: 1-11.
68. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman R M. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 2003: 198: 267-279.
69. Kadowaki N, Antonenko S, Ho S et al. Distinct cytokine profiles of neonatal natural killer t cells after expansion with subsets of dendritic cells. J Exp Med 2001: 193: 1221-1226.
70. Ikarashi Y, Mikami R, Bendelac A et al. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production. J Exp Med 2001: 194: 1179-1186.
71. Rissoan MC, Soumelis V, Kadowaki N et al. Reciprocal control of T helper cell and dendritic cell differentiation [see comments]. Science 1999: 283: 1183-1186.
72. Shreedhar V, Moodycliffe A M, Ullrich S E, Bucana C, Kripke M L, Flores-Romo L. Dendritic cells require T cells for functional maturation in vivo. Immunity 1999: 11: 625-636.